Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1970; 24(01/02): 302-303DOI: 10.1055/s-0038-1654236 Vorläufige Mitteilungen - Preliminary Reports - Communications Préliminaires Schattauer GmbH Exercise Induced Increase in Split Products of Fibrinogen[*] E. W Ferguson 1 Department of Physiology, University of Texas, Medical Branch, Galveston, Texas 77550 , L. B Nanninga 1 Department of Physiology, University of Texas, Medical Branch, Galveston, Texas 77550 › Author Affiliations Recommend Article Abstract Buy Article Full Text References References 1 Biggs R, MacFarlane R. G, Pilling J. Observations on fibrinolysis. Experimental activity produced by exercise or adrenaline. Lancet I.. 402. 1947 2 Bond T. P, Gelander D. R, Guest M. M. The effects of exercise on the coagulation and fibrinolytic systems. Fed. Proc 20: 56 1961; 3 Gash J. D, Woodfield D. G. Fibrinolytic response to moderate exercise in 50 healthy middle- aged subjects. Brit. med. J II: 658 1968; 4 Gelander D. R, Guest M. M. Euglobulin lysis time. Blood Coagulation, Hemorrhage and Thrombosis. 249 Edited by Tocantins L. M, Kazal L. A. Grune & Stratton; New York: 1955 5 Ferguson E. W, Guest M. M, Bond T. P. Exercise, blood coagulation and fibrinolytic activity. Fed. Proc 28: 785 1969; 6 Iatridis S. G, Ferguson J. H. Effect of physical exercise on blood clotting and fibrinolysis. J. appl. Physiol 18: 337 1963; 7 Nanninga L. B, Guest M. M. Preparation and properties of anticoagulant split product of fibrinogen and its determination in plasma. Thrombos. Diathes. haemorrh. (Stuttg.) 17: 440 1967; 8 Ware A. G, Guest M. M, Seegers W. H. Fibrinogen: with special reference to its preparation and certain properties of the product. Arch. Biochem 13: 231 1947; 9 Schwiclc H. G. Immunochemistry of fibrinogen. Thrombos. Diathes. haemorrh. (Stuttg.) Suppl 13: 85 1964; 10 Das P. C, Allan A. GE, Woodfield D. G, Gash J. D. Fibrin degradation products in sera of normal subjects. Brit. med. J 1967; part 4, 718. 11 Latallo Z. S, Fletcher A. P, Alkjaersig N, Sherry S. Inhibition of fibrin polymerization by fibrinogen proteolysis products. Amer. J. Physiol 202: 681 1962; 12 Bang N. U, Fletcher A. P, Alkjaersig N, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (fibrinolytic) states. III. Demonstration of abnormal clot structure by electron microscopy. J. clin. Invest 41: 935 1962;
